Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2022
Historique:
pubmed: 2 8 2022
medline: 21 9 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

The association between health-related quality of life (HRQoL) and care costs in people at risk for cognitive decline is not well understood. Studying this association could reveal the potential benefits of increasing HRQoL and reducing care costs by improving cognition. In this exploratory data analysis we investigated the association between cognition, HRQoL utilities and costs in a well-functioning population at risk for cognitive decline. An exploratory data analysis was conducted using longitudinal 2-year data from the FINGER study (n = 1,120). A change score analysis was applied using HRQoL utilities and total medical care costs as outcome. HRQoL utilities were derived from the Short Form Health Survey-36 (SF-36). Total care costs comprised visits to a general practitioner, medical specialist, nurse, and days at hospital. Analyses were adjusted for activities of daily living (ADL) and depressive symptoms. Although univariable analysis showed an association between cognition and HRQoL utilities, multivariable analysis showed no association between cognition, HRQoL utilities and total care costs. A one-unit increase in ADL limitations was associated with a -0.006 (p < 0.001) decrease in HRQoL utilities and a one-unit increase in depressive symptoms was associated with a -0.004 (p < 0.001) decrease in HRQoL utilities. The level of cognition in people at-risk for cognitive decline does not seem to be associated with HRQoL utilities. Future research should examine the level at which cognitive decline starts to affect HRQoL and care costs. Ideally, this would be done by means of cross-validation in populations with various stages of cognitive functioning and decline.

Sections du résumé

BACKGROUND
The association between health-related quality of life (HRQoL) and care costs in people at risk for cognitive decline is not well understood. Studying this association could reveal the potential benefits of increasing HRQoL and reducing care costs by improving cognition.
OBJECTIVE
In this exploratory data analysis we investigated the association between cognition, HRQoL utilities and costs in a well-functioning population at risk for cognitive decline.
METHODS
An exploratory data analysis was conducted using longitudinal 2-year data from the FINGER study (n = 1,120). A change score analysis was applied using HRQoL utilities and total medical care costs as outcome. HRQoL utilities were derived from the Short Form Health Survey-36 (SF-36). Total care costs comprised visits to a general practitioner, medical specialist, nurse, and days at hospital. Analyses were adjusted for activities of daily living (ADL) and depressive symptoms.
RESULTS
Although univariable analysis showed an association between cognition and HRQoL utilities, multivariable analysis showed no association between cognition, HRQoL utilities and total care costs. A one-unit increase in ADL limitations was associated with a -0.006 (p < 0.001) decrease in HRQoL utilities and a one-unit increase in depressive symptoms was associated with a -0.004 (p < 0.001) decrease in HRQoL utilities.
CONCLUSION
The level of cognition in people at-risk for cognitive decline does not seem to be associated with HRQoL utilities. Future research should examine the level at which cognitive decline starts to affect HRQoL and care costs. Ideally, this would be done by means of cross-validation in populations with various stages of cognitive functioning and decline.

Identifiants

pubmed: 35912737
pii: JAD215304
doi: 10.3233/JAD-215304
pmc: PMC9535559
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-632

Références

J Am Geriatr Soc. 2019 Jun;67(6):1138-1144
pubmed: 30809801
Sci Rep. 2015 Nov 25;5:17301
pubmed: 26601612
J Am Geriatr Soc. 2013 Mar;61(3):396-402
pubmed: 23414481
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):30-6
pubmed: 22214890
J Alzheimers Dis. 2015;47(2):479-86
pubmed: 26401569
Acta Psychiatr Scand. 2011 Nov;124(5):384-95
pubmed: 21838738
Ann Indian Acad Neurol. 2014 Jan;17(1):71-6
pubmed: 24753664
Health Soc Care Community. 2014 Jul;22(4):368-74
pubmed: 24313868
J Alzheimers Dis. 2014;42(4):1311-24
pubmed: 25024334
Nurs Open. 2019 Mar 19;6(3):849-859
pubmed: 31367408
J Geriatr Psychiatry Neurol. 2020 Sep;33(5):256-264
pubmed: 31645191
BMC Res Notes. 2019 Jan 14;12(1):18
pubmed: 30642397
Arch Gen Psychiatry. 1965 Jan;12:63-70
pubmed: 14221692
Value Health. 2014 Jul;17(5):570-7
pubmed: 25128050
Lancet. 2015 Jun 6;385(9984):2255-63
pubmed: 25771249
Qual Life Res. 2019 Dec;28(12):3187-3195
pubmed: 31364036
Alzheimers Dement. 2015 Aug;11(8):917-32
pubmed: 25858682
Int J Geriatr Psychiatry. 2013 Mar;28(3):256-64
pubmed: 23386588
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Health Econ. 2007 May 1;26(3):597-612
pubmed: 17069909
Alzheimers Dement. 2022 Jul 16;:
pubmed: 35841619
Annu Rev Stat Appl. 2017 Mar;4:283-315
pubmed: 28890906
Health Econ. 2004 Sep;13(9):873-84
pubmed: 15362179
J Chronic Dis. 1987;40(6):593-603
pubmed: 3298297
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Alzheimers Dement. 2013 Nov;9(6):657-65
pubmed: 23332672
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2012;19(3):421-32
pubmed: 22126333
Int J Geriatr Psychiatry. 2015 Feb;30(2):111-29
pubmed: 25320002
Value Health. 2018 Apr;21(4):471-481
pubmed: 29680105
J Alzheimers Dis. 2011;26(4):735-44
pubmed: 21709377
Dement Geriatr Cogn Disord. 2008;26(5):416-23
pubmed: 18946219
Epidemiol Psychiatr Sci. 2021 Feb 02;30:e10
pubmed: 33526166
Int J Environ Res Public Health. 2014 Sep 10;11(9):9345-60
pubmed: 25211775
BMC Geriatr. 2015 Jul 05;15:75
pubmed: 26142897
Int Psychogeriatr. 2016 Dec;28(12):2045-2054
pubmed: 27576786
Lancet Neurol. 2006 Sep;5(9):735-41
pubmed: 16914401
Electron Physician. 2018 Apr 25;10(4):6663-6671
pubmed: 29881529
BMC Health Serv Res. 2015 Sep 15;15:381
pubmed: 26373712
J Health Econ. 2002 Mar;21(2):271-92
pubmed: 11939242
J Aging Health. 2016 Dec;28(8):1448-1464
pubmed: 26818587
Med Care. 2004 Sep;42(9):851-9
pubmed: 15319610
Alzheimers Res Ther. 2020 Nov 18;12(1):154
pubmed: 33208190
BMJ Open. 2015 Nov 27;5(11):e008220
pubmed: 26614618
Epilepsy Res. 2018 Oct;146:87-93
pubmed: 30086483
Annu Rev Public Health. 2018 Apr 1;39:489-505
pubmed: 29328879
Int J Geriatr Psychiatry. 2008 Sep;23(9):963-71
pubmed: 18416451
Neuropsychiatr. 2012;26(2):72-7
pubmed: 22836551
Br J Gen Pract. 2015 Nov;65(640):e716-23
pubmed: 26500318
Alzheimers Dement. 2013 Jan;9(1):1-11.e3
pubmed: 23305821

Auteurs

Niels Janssen (N)

Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Ron L Handels (RL)

Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Department of Neurobiology, Care Science and Society, Division of Neurogeriatrics, Karolinska Institute, Stockholm, Sweden.

Anders Wimo (A)

Department of Neurobiology, Care Science and Society, Division of Neurogeriatrics, Karolinska Institute, Stockholm, Sweden.
Centre for Research & Development, Uppsala University/County Council of Gävleborg, Gävle, Sweden.

Riitta Antikainen (R)

Center for Life Course Health Research/Geriatrics, University of Oulu, Oulu, Finland.
Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.

Tiina Laatikainen (T)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Finland.
Joint Municipal Authority for North Karelia Social and Health Services (Siun sote), Finland.

Hilkka Soininen (H)

Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Department of Neurology, Kuopio University Hospital, Kuopio, Finland.

Timo Strandberg (T)

Institute of Health Sciences/Geriatrics, University of Oulu and Oulu University Hospital, Oulu, Finland.
Department of Medicine, Geriatric Clinic, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland.

Jaakko Tuomilehto (J)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.
South Ostrobothnia Central Hospital, Seinajoki, Finland.
Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.

Miia Kivipelto (M)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, UK.

Silvia M A A Evers (SMAA)

Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Centre for Economic Evaluation Utrecht, Utrecht, The Netherlands.

Frans R J Verhey (FRJ)

Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Tiia Ngandu (T)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH